Daily Wealth

About the Author Daily Wealth

In a nutshell, our investment philosophy here at DailyWealth is this: Buy things of extraordinary value at a time when nobody else wants them. Then sell when people are willing to pay any price. You see, at DailyWealth, we believe most investors take way too much risk. So our mission is to show you how to avoid risky investments, and how to avoid what the average investor is doing. We believe that you can make a lot of money – and do it safely – by simply doing the opposite of what is most popular.

iShares NASDAQ Biotechnology Index (ETF) (IBB): Healthcare Stocks Are on the Verge of a Double-Digit Bounce

Test tubes over financial data. Concept for Investing in Life Science.

By Brett Eversole

U.S. stocks are only a few points away from new all-time highs, but not every part of the U.S. market has been thriving. Health care stocks recently fell 12% from their August highs to their pre-election lows, hitting an eight-month low in the process.

Have they bottomed? Is it time to buy? Or is this the beginning of a major downtrend? Let’s take a closer look and find out..

Healthcare stocks were falling before the election, when Hillary Clinton was expected to win. The stock market expected things would stay “status quo” with Obamacare, and it didn’t think that would be good for healthcare companies’ profits.

Then, the election result surprised the markets. Trump was elected, and the sector soared. So where do we go from here?

History says more gains are likely. Specifically, double-digit gains are possible over the next year. Let me explain…

Two weeks ago, the Health Care Select Sector SPDR Fund (XLV) fell to an eight-month low. Take a look:

New eight-month lows don’t happen often. But look at what came next. After hitting their low, healthcare stocks turned upward, and they jumped nearly 4% the day after Trump was elected.

This upward trend isn’t surprising. It’s what tends to happen after a new eight-month low in healthcare stocks.

We’ve only seen new eight-month lows in XLV 10 other times going back to 2000. And they often end with a big reversal like we’re already seeing. Take a look:

After Extreme
All Periods

Since 2000, we tracked the gains that you would have seen if you used a “buy and hold” strategy. Healthcare stocks were typically up 1.2% over three months and 4.8% over the course of a year. But after an eight-month low, the typical returns were much higher.

XLV gained 4.2% over three months and 10% the year after similar multi-month lows in the past. This might not sound like much, but it’s actually a huge outperformance versus the sector’s typical returns.

Health care stocks were one of the market’s worst performers going into the election. But now, after an eight-month low, they could be one of the best.

The BioPortfolio is the only sure way to make profits trading biotech stocks. Learn more HERE and set up your top notch portfolio in seconds.


Stay Ahead of Everyone Else

Get The Latest Stock News Alerts